| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Characterization of in vivo metabolites of WR319691, a novel compound with activity against Plasmodium falciparum
|
Milner, Erin
|
|
2011
|
36 |
3 |
p. 151-158
|
article
|
| 2 |
Clinical pharmacokinetics of ketoprofen enantiomers in wild type of Cyp 2c8 and Cyp 2c9 patients with rheumatoid arthritis
|
Główka, Franciszek
|
|
2011
|
36 |
3 |
p. 167-173
|
article
|
| 3 |
Effects of myricetin, an anticancer compound, on the bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats
|
Li, Cheng
|
|
2011
|
36 |
3 |
p. 175-182
|
article
|
| 4 |
Explicit reformulations of the Lambert W-omega function for calculations of the solutions to one-compartment pharmacokinetic models with Michaelis–Menten elimination kinetics
|
Goličnik, Marko
|
|
2011
|
36 |
3 |
p. 121-127
|
article
|
| 5 |
In vitro characterization of rosiglitazone metabolites and determination of the kinetic parameters employing rat liver microsomal fraction
|
Calixto, Leandro Augusto
|
|
2011
|
36 |
3 |
p. 159-166
|
article
|
| 6 |
One-compartmental biometric blood loss calculation after cesarean section
|
Milosevic, Natasa
|
|
2011
|
36 |
3 |
p. 183-188
|
article
|
| 7 |
Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor
|
He, Kan
|
|
2011
|
36 |
3 |
p. 129-139
|
article
|
| 8 |
Renal excretion of apricitabine in rats: ex vivo and in vivo studies
|
Babayeva, Mariana
|
|
2011
|
36 |
3 |
p. 141-150
|
article
|
| 9 |
Validation of quinidine as a probe substrate for the in vitro P-gp inhibition assay in Caco-2 cell monolayer
|
Patil, Anand G.
|
|
2011
|
36 |
3 |
p. 115-119
|
article
|
Journal description